Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
by
藏田 泉
, 松本 功
, Tanaka Yuki
, 熊谷 嘉人
, 住田 孝之
, Inoue Asuka
, 近藤 裕也
, Ebe Hiroshi
, 新開 泰弘
, Kawaguchi Hoshimi
, Osada Atsumu
, Umeda Naoto
, 坪井 洋人
, Ishigami Akihito
in
Biological markers
/ Care and treatment
/ Cellular proteins
/ Citrullinated proteins
/ Development and progression
/ Gene expression
/ Genetic aspects
/ Health aspects
/ Identification and classification
/ Inter-alpha-trypsin inhibitor heavy chain 4
/ Medicine
/ Medicine & Public Health
/ Orthopedics
/ PAD
/ Research Article
/ Rheumatoid arthritis
/ Rheumatology
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
by
藏田 泉
, 松本 功
, Tanaka Yuki
, 熊谷 嘉人
, 住田 孝之
, Inoue Asuka
, 近藤 裕也
, Ebe Hiroshi
, 新開 泰弘
, Kawaguchi Hoshimi
, Osada Atsumu
, Umeda Naoto
, 坪井 洋人
, Ishigami Akihito
in
Biological markers
/ Care and treatment
/ Cellular proteins
/ Citrullinated proteins
/ Development and progression
/ Gene expression
/ Genetic aspects
/ Health aspects
/ Identification and classification
/ Inter-alpha-trypsin inhibitor heavy chain 4
/ Medicine
/ Medicine & Public Health
/ Orthopedics
/ PAD
/ Research Article
/ Rheumatoid arthritis
/ Rheumatology
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
by
藏田 泉
, 松本 功
, Tanaka Yuki
, 熊谷 嘉人
, 住田 孝之
, Inoue Asuka
, 近藤 裕也
, Ebe Hiroshi
, 新開 泰弘
, Kawaguchi Hoshimi
, Osada Atsumu
, Umeda Naoto
, 坪井 洋人
, Ishigami Akihito
in
Biological markers
/ Care and treatment
/ Cellular proteins
/ Citrullinated proteins
/ Development and progression
/ Gene expression
/ Genetic aspects
/ Health aspects
/ Identification and classification
/ Inter-alpha-trypsin inhibitor heavy chain 4
/ Medicine
/ Medicine & Public Health
/ Orthopedics
/ PAD
/ Research Article
/ Rheumatoid arthritis
/ Rheumatology
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
Journal Article
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis
藏田 泉,
松本 功,
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Background\\nAnticitrullinated protein antibodies (ACPA) and citrullinated proteins play key roles in the pathogenesis of rheumatoid arthritis (RA). Many candidate citrullinated antigens have been identified in joints, but citrullinated proteins in sera are mostly uncertain in patients with RA. We explored the expression of citrullinated proteins in joints and sera of experimental arthritis, and we further investigated their specific expression correlated with the disease activity in patients with RA.\\n\\nMethods\\nCitrullinated protein expression in tissues was examined by IHC in peptide glucose-6-phosphate isomerase-induced arthritis (pGIA). Serum citrullinated proteins from pGIA were examined by Western blotting, and the sequence was identified by MS. With the same methods, serum citrullinated proteins were analyzed in patients with RA, primary Sjögren's syndrome, systemic lupus erythematosus, and osteoarthritis as well as in healthy subjects, by Western blotting and MS. In patients with RA, the relationship between the expression of the identified protein (inter-alpha-trypsin inhibitor heavy chain 4 [ITIH4]) and clinical features was evaluated, and the levels of citrullinated ITIH4 were compared before and after biological treatment. The antibody response against citrullinated ITIH4 peptide was measured by enzyme-linked immunosorbent assay.\\n\\nResults\\nCitrullinated proteins were detected specifically in arthritic joints and sera from pGIA relative to controls. In sera, a common band of citrullinated protein at 120 kDa was revealed, and it fluctuated in parallel with arthritis score of pGIA by Western blotting. Interestingly, in 82% of RA patient sera, similar bands of citrullinated protein were specifically detected. These proteins were identified as citrullinated ITIH4, and especially the R438 site was commonly citrullinated between mice and humans. Citrullinated ITIH4 levels were associated with clinical parameters such as C-reactive protein (CRP), rheumatoid factor, and Disease Activity Score in 28 joints as measured by CRP in patients with RA. Its levels were decreased in correlation with the reduction of disease activity score after effective treatment in patients with RA. Moreover, antibody response to citrullinated epitope in ITIH4 was specifically observed in patients with RA.\\n\\nConclusions\\nOur results suggest that serum citrullinated ITIH4 was specifically increased in patients with RA and could be a novel biomarker for assessing disease activity in patients with RA.
Publisher
BioMed Central,BioMed Central Ltd,BMC
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.